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ABSTRACT DNA replication forks that are stalled by DNA damage activate an S-phase checkpoint that prevents irreversible fork arrest
and cell death. The increased cell death caused by DNA damage in budding yeast cells lacking the Rad53 checkpoint protein kinase is
partially suppressed by deletion of the EXO1 gene. Using a whole-genome sequencing approach, we identiﬁed two additional genes,
RXT2 and RPH1, whose mutation can also partially suppress this DNA damage sensitivity. We provide evidence that RXT2 and RPH1 act
in a common pathway, which is distinct from the EXO1 pathway. Analysis of additional mutants indicates that suppression works
through the loss of the Rpd3L histone deacetylase complex. Our results suggest that the loss or absence of histone acetylation, perhaps
at stalled forks, may contribute to cell death in the absence of a functional checkpoint.
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THE process of DNA replication must ensure accuratechromosome duplication, even when contending with
damaged DNA templates. Replication and DNA repair, take
place on chromatin templates and, as a consequence, are
inﬂuenced by chromatin remodelers and covalent histone
modiﬁcations. The ability of cells to sense and respond ap-
propriately to conditions that affect replication fork progres-
sion is crucial to maintain cell viability and genome integrity
(Ciccia and Elledge 2010; Labib and De Piccoli 2011; Zeman
and Cimprich 2014). The “checkpoint” that senses DNA dam-
age and stalled DNA replication forks functions as an impor-
tant anticancer barrier (Bartkova et al. 2005; Gorgoulis et al.
2005). Many anticancer drugs work by interfering with DNA
replication and their efﬁcacy may, therefore, be inﬂuenced by
the checkpoint status of the cancer. Thus, understanding the
processes that maintain stable replication forks through chro-
matin may contribute to improving therapies.
In Saccharomyces cerevisiae, as in multicellular eukary-
otes, DNA damage checkpoints involve DNA damage detec-
tion, signal ampliﬁcation, and signal transduction directed
through phosphoinositide 3-kinase-related protein kinases
(PIKK; Mec1 and Tel1 in yeast) that activate effector kinases
(Rad53, Chk1, and Dun1 in yeast). Checkpoint kinases reg-
ulate many aspects of cell metabolism in response to DNA
damage (Zegerman and Difﬂey 2009). These include block-
ing cell cycle progression (Allen et al. 1994), suppressing late
origin ﬁring (Santocanale and Difﬂey 1998; Shirahige et al.
1998; Santocanale et al. 1999; Lopez-Mosqueda et al. 2010;
Zegerman and Difﬂey 2010), altering global gene expression
patterns (Zhou and Elledge 1993; Allen et al. 1994; Huang
et al. 1998), preventing irreversible DNA replication fork ar-
rest (Lopes et al. 2001; Tercero and Difﬂey 2001; Tercero
et al. 2003), and upregulating deoxyribonucleoside triphos-
phate (dNTP) levels (Desany et al. 1998; Zhao et al. 1998).
The regulation of dNTP levels by the DNAdamage checkpoint
is essential for cell survival, even in the absence of DNA dam-
age. Thus, the survival of mec1D or rad53D checkpoint mu-
tants requires conditions in which dNTP levels have been
elevated, such as deletion of the ribonucleotide reductase
(RNR) inhibitor Sml1 (Zhao et al. 1998). However, this is
not sufﬁcient to support viability in the presence of DNA
damage, such as that caused by methyl methanesulfonate
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(MMS) or hydroxyurea (HU). We have previously shown that
replication forks in rad53D and mec1D mutant strains are un-
able to progress through damaged DNA, and that reinstating
the checkpoint after fork stalling cannot rescue fork progres-
sion defects. We proposed that this irreversible replication fork
arrest is one of the primary reasons for genotoxicity in these
strains (Tercero and Difﬂey 2001; Tercero et al. 2003).
Despite its potential importance, we do not understand the
natureof the irreversible forkcatastrophe incheckpointmutants,
nor doweknowhow theDNAdamage checkpoint protects forks
from this fate. Chromatin immunoprecipitation experiments
suggested that the checkpoint might prevent loss of replisome
components from the fork (Lucca et al. 2004; Cobb et al. 2005),
but more recent work has shown that stalled replisomes appear
to be stable even in the absence of a functional checkpoint, both
in yeast and human cells (De Piccoli et al. 2012; Dungrawala
et al. 2015). We have taken an unbiased genetic approach to
further understand why checkpoint mutant cells are hypersen-
sitive to DNA damage, revealing a connection between chroma-
tin state and replication fork stability.
Materials and Methods
Strains and plasmids
All strains used are listed in Supplemental Material, Table S1
and are derived fromW303 (ade2-1 ura3-1 his3-11, 15 trp1-1
leu2-3, 112 can1-100). Genes were deleted by gene replace-
ments of the endogenous wild-type allele via genetic recom-
bination with the corresponding drug-resistant cassettes,
obtained by the PCR strategies described previously for
KANMX6 (Longtine et al. 1998), NATMX6 (Van Driessche
et al. 2005), NATNT2, and HPHNT1 (Janke et al. 2004). His-
tone mutants were made by plasmid shufﬂe and checked by
PCR, western blotting, and sequencing with plasmids carry-
ing the wild-type and mutant H3K36R or H3K9R histone
genes (pDM9, MBB286, and pWZ414-F53) that were previ-
ously described (Quan and Hartzog 2010).
YEplac112, YEplac112-Rpd3, and YEp-lac112-rpd-3H150A
were previously described (Kadosh and Struhl 1998). The
pRS303-RPH1 plasmid was constructed as follows. The
RPH1 genomic fragment was ampliﬁed by PCRusing Phusion
DNA polymerase with oligonucleotides 59-ATGCCATCCCGG
GACACAAAAAAAGCCCTTATAAC-39 and 59-GCTGCACACTA
GTTCAGTTTAAAGGTGTACTCTG-39, digested with XmaI-SpeI,
and cloned into XmaI-SpeI-cut pRS303. rph1-H235A, rph1-
S652A, and rph1-S652D mutants were created by site-directed
mutagenesis of RPH1 and the RPH1 gene was sequenced to
verify correct substitution of the selected fragments. The rph1-
wild-type and point mutant strains were created by targeting
NheI-digested constructs pRS303-RPH1, pRS303-rph1-H235A,
pRS303-rph1-S652A, or pRS303-rph1-S652D into the HIS3 lo-
cus of an rph1D rad53D strain.
Cell growth, media, and drug sensitivity assays
Cells were grown at 30 in YPD medium (1% yeast extract,
2% bacto peptone, and 2% glucose) unless indicated. When
backcrossing the isolated checkpoint suppressors with the
parental strain, we dissected tetrads and replicated the
spores into media containing MMS and phloxine B plates to
help distinguish the spores that were surviving MMS. To con-
ﬁrm the suppressor mutations, a minimum of two indepen-
dent deletions were tested for each gene to exclude
mutations that might have arisen during the deletion proce-
dure. We also backcrossed the strain deleted for each tested
gene with the parental one to obtain a heterozygous diploid
and analyzed the cosegregation of the deletion with the sup-
pressor phenotype after sporulation. In all cases that MMS
was used in plates, MMS was added to the melted agar at the
indicated concentration just before pouring the plates and
the MMS-containing plates were dried with the lid in place
for exactly 24-hr before use. Plates were sealed with paraﬁlm
during incubation. Dilution-plating assays were a 1:10 dilu-
tion series of cultures on the indicated plates and incubated
for 3 days at 30, or irradiated with ultraviolet (UV) radiation
at the indicated dosages and then incubated for 3 days at 30.
For the MMS sensitivity assays in a single S phase, the in-
dicated strains were released from G1 arrest at 30 in YPD
medium containing 0.015% MMS, and cell survival was
scored during a-factor arrest and at the indicated time points.
Relative survival was calculated as the percentage of survival
of each strain relative to the survival data of the sml1D con-
trol strain obtained on the same day. Cell cycle blocks with
a-factor were as described previously (Difﬂey et al. 1994).
Cycloheximide was used at a concentration of 100 mg/ml.
Protein extracts
Proteinswere extracted byTCAas described (Foiani et al.1994)
and were then loaded on a 15% acrylamide-bisacrylamide gel,
dried, and exposed in a Fujiﬁlm FLA-5000 phosphorimager.
Whole-genome sequencing
DNA for whole-genome sequencing was extracted by the
CTAB protocol as previously described (Moriel-Carretero
and Aguilera 2010) and sheared using the Covaris S2 to
300 bp. The sheared DNA samples were end repaired,
poly-A tailed, and Illumina Single-End Adapters were ligated
(paired-end protocol; Illumina, San Diego, CA). The standard
protocol by Illumina was adjusted to ﬁt our samples. We used
Agencourt AMPure XP beads (AMPure bead protocol; Beck-
man Coulter) at 0.83 ratio to size select out adapter dimers
after adapter ligation. The Illumina kit Phusion enzyme was
replaced by Kapa HiFi HotStart ready mix (Kapa Biosystems,
Cape Town, South Africa). Post PCR, we used AMPure XP
beads at a 1:1 ratio to maintain size integrity, which also
helped us to optimize the pH and other salt concentrations
to allow us to use the Invitrogen SizeSelect E-gel system
(SizeSelect gel protocol; Life Technologies). Unlike for the
Illumina paired-end sample preparation protocol, we ran the
PCR before the gel. This improved visualization of the prod-
uct and removal of the correct band. To aid us in removing
any gel residue that would cause issues in later quality con-
trol (QC) and cluster formation, we puriﬁed with a QIAquick
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gel extraction kit (Gel puriﬁcation protocol; QIAGEN, Valen-
cia, CA). After a ﬁnal QC step using the DNA 1000 BioAna-
lyser 2100 chip (Agilent, Santa Clara, CA), the libraries were
ready for Flowcell cluster formation on a cluster station fol-
lowed by Illumina paired-end sequencing on either the Ge-
nome Analyzer IIx or HiSeq 2500with a read length of 36 and
101 bp, respectively. Due to the increased output of the HiSeq
2500, we were able to multiplex 17 samples per lane.
Single-nucleotide variant calling in MMS-resistant
suppressor strains
Paired-end reads were aligned to the yeast sacCer2 genome
assembly using Novoalign 2.07.14 (http://novocraft.com),
with the parameters for the mean and SD of the expected
size distribution set to 175 and 125, respectively. Alignments
for 101-bp paired-end reads were postprocessed for removal
of reads that could have arisen from PCR duplication (picard-
tools 1.81; http://sourceforge.net/projects/picard/). Approx-
imately 96% of paired reads were found to align concordantly
to the reference genome resulting in a median coverage of
2003 across all samples.
Base-levelnucleotidecountswereobtainedusingdeepSNV
1.2.3 (Gerstung et al. 2012) with a minimum base quality
threshold of 30. Single-nucleotide variant (SNV) calling
was performed simultaneously across the relevant sample
groups per experiment using scripts written in Python.
A minimum allele count of 5 and minimum allele frequency
of 0.25 were applied for the rad53D chk1D exo1D (S64Ba vs.
W64Aa strain) and exo1D rad53D (YMS6 vs. YGDP939
strain) genome sequencing experiments. These thresholds
were increased to a minimum allele count of 20 and minimum
allele frequency of 0.40 for the rad53D batch sequencing exper-
iment (MMS-resistant, suppressor-containing strains vs. the
YJT75 strain). Multiallelic loci and variants identiﬁed in any
of the control samples with an allele frequency of 0.1 or above
were discarded. Variant annotation was performed with snpEff
3.0j (Cingolani et al. 2012) using the sacCer2.61 Ensembl ge-
nomic database provided by the package.
SNVs that passed the above criteria were further ﬁltered to
only include those that were labeled as nonsynonymous
mutations and had aminimumallele frequency of 0.7. Among
the top 10 genes thatwere found to have a recurringmissense
mutation, 14 mutations were found in genes involved in
nonsense-mediated mRNA decay (NMD2, DCP2, XRN1, and
UPF3). Thus, we tested the deletions of a total of 32 nones-
sential genes related to RNA and DNA metabolism (NMD2,
XRN1, UPF3, SIR1, SIR4, ESC1, PPH22, MOT2, CTF18, SAC3,
RAI1, HRB1, SUM1, YKU70, TDA7, MLP2, SPT7, DAS1,
VPS72, STB6, RTT106, BMH2, MPT5, DEF1, LCL3, HFM1,
ARP8, NUP100, SWD1, RIF1, BDF2, and NUP170) and iden-
tiﬁed three pathways: nonsense-mediated mRNA decay, si-
lencing of the mating-type loci HMR and HML (HM loci), and
the Rpd3L histone deacetylase (HDAC) complex.
If we apply a less-stringent minimum allele frequency
(0.4 instead of 0.7) and consider mutations in Rph1, Rpd3L
components (as deﬁned for Rpd3L-expanded, Shevchenko
et al. 2008), chromatin silencing [deﬁned as the gene ontol-
ogy (GO) processes of “chromatin silencing at silent mating-
type cassette,” “chromatin-silencing complex,” or “negative
regulation of gene silencing”], mRNA decay (deﬁned as the
GO term “nuclear-transcribed mRNA catabolic process, non-
sense-mediated decay”), or MMS hyperresistance, we can
assign a mutation to 63 out of the 95 suppressors sequenced.
Given that we did not analyze mutations mapping outside
ORFs, which might affect also the gene expression levels of
genes related to these pathways, and that there are many
possible unknown factors that can affect chromatin acetyla-
tion, chromatin silencing, or MMS resistance, probably most
of the 95 suppressors sequenced can be explained by one of
the three identiﬁed pathways, although we cannot rule out
other pathways.
Data availability
Strains and plasmids are available upon request. The authors
afﬁrm that all data necessary for conﬁrming the conclusions of
thearticlearepresentwithin thearticle,ﬁgures, and tables.All
raw sequence data and processed SNV calls can be accessed
with Gene Expression Omnibus accession GSE113869. Sup-
plemental material available at Figshare: https://doi.org/
10.25386/genetics.7473365.
Results
Loss of EXO1 and RXT2 suppresses the DNA damage
sensitivity of rad53D cells
We previously reported that deletion of the EXO1 gene can
suppress the sensitivity of rad53D cells to MMS (Segurado
and Difﬂey 2008). However, we became aware that the strik-
ing resistance to MMS seen in one of our published rad53D
exo1D strains (YMS6) was not seen in other genetic back-
grounds (K. Labib and G. De Piccoli, personal communica-
tion). This led us to consider that additional mutations in
YMS6 may have contributed to its heightened MMS resis-
tance. To test this, we sequenced the genome of YMS6 and
compared it to a newly generated exo1D rad53D strain
(YGDP939), which did not show such pronounced MMS re-
sistance. We established criteria to deﬁne mutations (see
Materials and Methods and Table S2) and we focused on
mutations within ORFs that changed coding sequences. We
found seven such mutations. Six were missense mutants, but
one was a nonsense mutation in the RXT2 gene (rxt2-
Q102STOP), which truncated the last 329 amino acid resi-
dues of the encoded protein (Table S2). We remade this
truncation; Figure 1A shows that, like the original mutant,
this reconstructed rxt2-Q102STOP partially suppresses the
MMS sensitivity of rad53D. Furthermore, complete deletion
of the RXT2 gene conferred similar MMS resistance (Figure
1A). To examine the effect of RXT2 and EXO1 deletion on
viability in a single cell cycle, cells from various strains were
synchronized in G1 phase with a-factor mating pheromone
and released from the G1 arrest in the presence of MMS. As
Checkpoint Suppressor Mutants 505
shown in Figure 1B, rxt2-Q102STOP partially restored the
viability lost by rad53D upon passage through S phase in
the presence of MMS, indicating that wild-type Rxt2 contrib-
utes to cell death in rad53D cells treated with MMS even in a
single S phase. Therefore, both rxt2-Q102STOP and exo1D
can suppress the DNA damage sensitivity of rad53D cells in-
dividually, with rxt2-Q102STOP being a better growth sup-
pressor under chronic MMS treatment. The suppression by
rxt2-Q102STOP and exo1D were additive, indicating that
they are in different pathways (Figure 1C). Thus, muta-
tion/loss of both EXO1 and RXT2 contributed to the suppres-
sion of lethality in MMS previously seen in YMS6 (Segurado
and Difﬂey 2008). Our previous conclusion that deletion of
EXO1 suppresses irreversible fork arrest in rad53D cells is
likely unaffected by this discovery, since the strains used in
the replication fork stability experiments were derived sepa-
rately from YMS6 and showed MMS sensitivity similar to
YGDP939. Moreover, neither viability nor irreversible fork
arrest in the rad53D chk1D strain and the mec1D strain were
suppressed by deletion of EXO1, consistent with our previous
conclusion that these other checkpoint kinases have separate
roles in fork stabilization. Nonetheless, the results presented
above identiﬁed a new Rad53 suppressor (rxt2) and sug-
gested that multiple pathways might contribute to the DNA
damage sensitivity of rad53 mutants.
The Rpd3L HDAC contributes to DNA damage sensitivity
in rad53D cells
Rxt2 is a subunit of Rpd3L, a HDAC complex whose catalytic
subunit is Rpd3. Rpd3L is in “balance” with another HDAC
complex, Rpd3S (Carrozza et al. 2005), which shares several
subunits with Rpd3L, including Rpd3. However, each complex
also contains several speciﬁc subunits (Carrozza et al. 2005).
Whereas Rpd3L localizes primarily to promoter regions to re-
press transcription, Rpd3S is recruited at the 39-end of tran-
scribed regions (Joshi and Struhl 2005). To address whether
the suppression was due to a defect in Rpd3L HDAC, we stud-
ied the effect of deleting other Rpd3L components on theMMS
sensitivity of rad53D. Both sds3D and rpd3D suppressed the
MMS sensitivity of rad53D as well as rxt2-Q102STOP (Figure
2A). However, the deletion of Rpd3S-speciﬁc components,
such as Eaf3 or Rco1, did not suppress (Figure 2A). Therefore,
suppression is speciﬁc to the loss of Rpd3L.
We sought to determine if Rpd3 catalytic activity was in-
volved in the suppression. For this purpose, we expressed Rpd3
and anRpd3-H150AHDAC catalyticmutant (Kadosh and Struhl
1998) in our rpd3D rad53D sml1D background. As shown in
Figure 2B, expression of Rpd3, but not Rpd3-H150A, prevented
the suppression, making cells sensitive to MMS.
The deletion of RPD3 had previously been shown to sup-
press the sensitivity to UV and HU of rad9 and mec1 check-
point mutants. This suppression was shown to be functional
spindle assembly checkpoint-dependent (Scott and Plon
2003). However, we found that deletion of the spindle as-
sembly checkpoint gene MAD1 had no effect on the suppres-
sion of MMS sensitivity in rad53D cells by rpd3D (Figure S1),
indicating that the suppression was independent of the spin-
dle assembly checkpoint. Furthermore, although Mec1- and
Tel1-dependent cross talk between the DNA damage and the
spindle assembly checkpoint has been suggested (Kim and
Burke 2008), deletion of TEL1 had no effect on the suppres-
sion by rpd3D (Figure S1).
Identiﬁcation of RPH1 deletion as a new
checkpoint suppressor
To further understand how checkpoints promote viability in
the presence of DNA damage, we were interested in identi-
fying other suppressors in an unbiasedmanner. Given that our
previous report (Segurado and Difﬂey 2008) identiﬁed exo1D
as a suppressor of the DNA damage sensitivity of rad53D but
not rad53D chk1D mutant cells, we isolated and character-
ized colonies from rad53D chk1D exo1D cells that survived on
Figure 1 Identiﬁcation of rxt2 as an extragenic
suppressor of the MMS sensitivity of checkpoint
mutants. (A) Suppression of the rad53D sensitivity
to chronic MMS treatment by exo1D, rxt2-
Q102STOP, rxt2D, and double mutants. Strains:
YJT72, YJT75, YGDP939, YMS6, 938rxt2, 939rxt2,
and YBG628 (B) Suppression of the rad53D sensi-
tivity to MMS by rxt2-Q102STOP, exo1D, and dou-
ble mutants in a single S phase was studied by
treating the indicated strains with 0.015% MMS
for the indicated time points after release from
G1 synchronization, and scoring cell survival by col-
ony-forming units after plating in fresh media. The
mean of at least three experiments is shown.
Strains: YBG022, YBG023, YBG245, YBG026, and
939rxt2. (C) Relative survival of S-phase cells treat-
ed with MMS 0.015% for 2 hr with respect to the
survival of the sml1D control strain (YBG022).
Strains: YBG023, YBG245, YBG026, and 939rxt2.
The mean and SEM of at least three experiments is
shown. * P , 0.05 and ** P , 0.005 (Student’s
unpaired t-test).
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plates containing MMS. One such suppressor was back-
crossed ﬁve times with the parental strain prior to whole-
genome sequencing (see Materials and Methods and Table
S3). Among the 12 nonsilent mutations in ORFs, we only
found one mutation that caused a protein truncation: a non-
sense mutation in the RPH1 gene causing a deletion of the
last 340 amino acids of the 796-amino acid Rph1 protein
(rph1-R456STOP). We remade this truncation in an unmuta-
genised genetic background and showed that the rph1-
R456STOP truncation promoted levels of survival in the
rad53D chk1D exo1D background very similar to those of
the strain carrying the original suppressor (Figure 3A).
rph1-R456STOP also suppressed the sensitivity of rad53D
cells to other DNA-damaging agents including UV radiation,
camptothecin (CPT), and HU, but this suppression was never
as striking as that seen in MMS (Figure S2A). The complete
deletion of the RPH1 gene also promoted the resistance of
rad53D chk1D exo1D cells to DNA damage (Figure 3B). More-
over, deletion of RPH1 partially suppressed the MMS sensi-
tivity of rad53D (Figure 3E), rad53D chk1D, and mec1D
checkpoint mutant strains (Figure 3B). Deletion of RPH1 also
partially suppressedMMS sensitivity within a single S phase in
an a-factor block and release experiment (Figure 3, C and D).
The deletion of EXO1 improved the survival of rph1D
rad53D both in a single-cell cycle experiment (Figure 3, C
and D) and upon chronic exposure to MMS (Figure 3E) in-
dicating that, as in the case of Exo1 and Rxt2, Exo1 and Rph1
also act in separate pathways. We wondered whether the
suppression caused by rph1 was related to that caused by
Rpd3L loss. As shown in Figure 3F, Rxt2 and Rph1 were
epistatic for the suppression, indicating that they act in the
same pathway.
Loss of Rph1 demethylase activity is not sufﬁcient
for suppression
Rph1 is a JmjC domain-containing histone demethylase. De-
letion of the other known histone demethylases (Jhd1, Jhd2,
or Gis1) did not show any suppression of the rad53D sensi-
tivity to MMS (Figure 4A), arguing that the suppression is
speciﬁc for the loss of Rph1. Rph1 demethylates histone H3
lysine 36 (H3K36) and is the only known demethylase for the
trimethylated state of H3K36. If suppression was due to an
accumulation of H3K36 methylation, it should require the
only known H3K36 methyltransferase, Set2. However, as
shown in Figure 4B, rph1D-induced suppression of the
rad53D sensitivity to MMS still occurred in set2D cells.
Rph1 can also demethylate H3K9 in vitro, although this mod-
iﬁcation has not been detected in yeast in vivo (Klose et al.
2007). To exclude the role of H3K36 or H3K9 methylation,
we constructed strains in which all copies of the histone H3
and H4 genes (HHT1, HHT2, HHF1, and HHF2) were deleted
from the genome and supplemented by a plasmid with a
single copy of HHF, and either a wild-type copy of HHT or
the nonmethylatable hht2-K36R or hht2-K3K9R mutants
(Quan and Hartzog 2010). As shown in Figure 4C, neither
hht2-K36R nor hht2-K3K9R prevented the suppression
caused by rph1D. To address if any other histone methylation
was responsible for the suppression, we eliminated the other
two known histone methyltransferases, Set1 and Dot1, with
no effect on rph1D-induced suppression either (Figure 4B).
These experiments show that rph1D-induced suppression of
the rad53D sensitivity to MMS is not caused by the histone
demethylase function of Rph1. To test the possibility that
suppression might be due to demethylation of some nonhis-
tone substrate, we constructed strains expressing either the
wild-type RPH1 gene or a catalytic-deﬁcient rph1-H235Amu-
tant, which disrupts Rph1 demethylase activity (Liang et al.
2011). In each case, expression was driven by the RPH1 pro-
moter at the HIS3 locus in a rph1D rad53D background. As
shown in Figure 4D, both the wild-type Rph1 and rph1-
H235A demethylase mutant fully prevented the suppression
caused by rph1D. Therefore, the elimination of the Rph1 de-
methylase function is not sufﬁcient to suppress the MMS
sensitivity of rad53D, indicating that Rph1 must have a func-
tion independent of its demethylase activity.
Identiﬁcation of additional suppressor pathways
Finally, we asked whether additional pathways might con-
tribute to suppression. We isolated 100 independent rad53D
sml1D suppressors from MMS plates and conﬁrmed their
Figure 2 The loss of Rpd3L histone deacetylase
suppresses the MMS sensitivity of checkpoint mu-
tants. (A) The nonsense mutation rxt2-Q102STOP,
and deletions in Rpd3 or the Rpd3L-speciﬁc compo-
nent Sds3, but not the Rpd3S-speciﬁc component
Rco1 or Eaf3, suppress the rad53D sensitivity to
MMS. Strains: YJT72, YJT75, YBG245, YBG615,
YBG369, YBG618, and YBG616. (B) Expression
of Rpd3, but not rpd3-H150A histone deacetylase
catalytically dead mutant, prevents the suppression by
rpd3D. Strains: YJT72+YEplac112, YJT75+YEplac112,
YBG369+YEplac112, YBG369+YEplac112-Rpd3,
and YBG369+YEplac112-rpd3-H150A.
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resistance to MMS. We then performed whole-genome sequenc-
ing on the 95 remaining MMS-resistant suppressors (see
Materials and Methods and Table S4). By focusing on nonsilent
codingmutations, of which therewas an average of 14 per strain,
and, in particular, nonsensemutations ofwhich therewere a total
of 43 across the 95 mutant strains, we were able to prioritize
mutations for retesting. We found RPH1, RPD3, and SAP30mu-
tated in 4 of our 95 suppressors (Table S4), though we did not
ﬁnd RXT2 or the remaining Rpd3L subunits, indicating that the
screen was not saturated. We initially chose 32 genes mutated in
the suppressor strains, which had been implicated in nucleic acid
metabolism to test further (seeMaterials andMethods).We found
that the sensitivity toMMSof rad53D cellswas suppressed by the
deletion of 6 of the 31 candidates: the nonsense-mediated
mRNA decay (NMD) factors NMD2, UPF3, and XRN1, and the
chromatin-silencing factors SIR1, SIR4, and ESC1.
nmd2D and upf3D strongly suppress the MMS sensitivity
of rad53D cells, while xrn1D can also suppress, despite the
fact that xrn1D mutants have a growth defect (Kipling et al.
1991) (Figure 5A). nmd2D also caused slightly increased re-
sistance to other DNA-damaging agents such as CPT or UV
(Figure 5B). However, we found that deletion of NMD2 also
signiﬁcantly enhanced the survival of RAD53 cells in MMS,
indicating that this effect is not checkpoint-speciﬁc (Figure
5B) and suggesting that deletion of NMD factors confers a
general increased resistance to DNA damage.
Theﬁnding that deletion of SIR1, SIR4, or ESC1 suppressed
the DNA damage sensitivity of rad53D cells was consistent
with previous work (Hu et al. 2001), and suggested a role for
chromatin silencing. We set out to understand how chroma-
tin silencing may be involved in DNA damage sensitivity. In S.
cerevisiae, chromatin silencing has been described at three
Figure 3 Identiﬁcation of rph1 as an extragenic
suppressor of the MMS sensitivity of checkpoint
mutants. (A) Suppression of the rad53D chk1D
exo1D sensitivity to MMS by the nonsense mutation
rph1-R456STOP. Strains: W303-1A, YJT72, W64Aa,
S64Ba, and YBG617. (B) rph1D suppression of the
sensitivity to MMS of rad53D chk1D, rad53D
chk1D exo1D, and mec1D. Strains: YJT72, YBG611,
2609CRS, YMS167, W6RPH1D1, YJT74, and
YBG612. (C) Suppression of the rad53D sensitivity
to MMS by rxt2-Q102STOP, exo1D, and double mu-
tants in a single S phase, as in Figure 1B. Strains:
YBG023, YBG034, YBG026, and YBG032. (D) Rel-
ative survival of S-phase cells as in Figure 1C. * P ,
0.05 and ** P , 0.005 (Student’s unpaired t-test).
Strains: YBG022, YBG023, YBG034, YBG026, and
YBG032. (E) Suppression of the rad53D sensitivity to
chronic MMS treatment by exo1D, rph1D, and dou-
ble mutants. Strains: YBG022, YBG023, YBG034,
YBG026, and YBG032. (F) Epistatic suppression of
the rad53D sensitivity to a single cell cycle (left
panel) and chronic MMS treatment (right panel)
by rxt2-Q102STOP and rph1D. * P , 0.05 and
** P , 0.005 (Student’s unpaired t-test). Strains:
YBG022, YBG023, YBG245, YBG034, and YBG348.
WT, wild-type.
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separate groups of loci: the silent mating-type cassettes (HML
and HMR), telomeres, and rDNA. Silencing at the HM loci
requires all four SIR genes (SIR1-4), whereas telomere posi-
tion effect requires SIR2-4 and rDNA silencing requires only
SIR2 [reviewed in Rusche et al. (2003)]. Figure 6A shows that
deletion of any one of the four silencing factors suppressed
the MMS sensitivity of rad53D. Since Sir1 has only been
shown to be required for silencing at the HM loci, this sug-
gested that the suppression might work through deregulated
HM expression. Consistent with this,MAT heterozygosity has
been shown to confer DNA damage hyperresistance (Friis
and Roman 1968; Heude and Fabre 1993; Valencia-Burton
et al. 2006).
If the suppression is due to inappropriate expression of HM
loci, then the suppression due to SIR gene deletion should
require the presence of the HM loci. As shown in Figure 6B,
the deletion of HML in MATa cells fully prevented the sup-
pression caused by sir1D, sir2D, sir4D, and esc1D. Similarly,
deletion of HMR in MATa cells fully prevented the suppres-
sion caused by sir4D. HM derepression allows haploid yeast
cells to express both a- and a-mating-type (MAT) genes, and
thus, gene expression patterns are regulated as in diploids.
Therefore, we predicted that the deletion of SIR or ESC1
genes should not suppress the DNA damage sensitivity of
rad53D/rad53D diploids. As shown in Figure 6C, the en-
hanced MMS sensitivity of rad53D/rad53D diploid cells
was not suppressed when one or both SIR2, SIR4, or ESC1
copies were deleted, conﬁrming that the suppression caused
by sir2D, sir4D, and esc1D is a consequence of the mating-
type heterozygosity in haploids.
Because Rpd3 antagonizes Sir2-dependent silent chroma-
tin propagation (Zhou et al. 2009) and the cellular pool of Sir
factors is limiting (Maillet et al. 1996), we considered the
possibility that the suppression observed in the absence of
Rpd3L is due to increased Sir spreading and dilution of the
silencing at the HM loci. However, the suppression by rph1D
and rxt2-Q102STOPwas not prevented by HML deletion, nor
was it haploid-speciﬁc (Figure S3), indicating that this is not
a consequence of mating-type heterozygosity.
Discussion
Using an unbiased approach, we found several pathways that
contribute to the DNA damage sensitivity of rad53Dmutants.
Deletion of NMD and mating-type silencing made both
rad53D and RAD53 cells more resistant to DNA damage,
and were therefore not characterized in detail (Figure 5
and Figure 6; Haber 2012). Loss of NMD has been shown
Figure 4 The suppression by rph1D is not caused
by the lack of Rph1 demethylase activity. (A) Dele-
tion of Jhd1, Jhd2, or Gis1 does not suppress the
MMS sensitivity of rad53D. Strains: YBG022, YBG023,
YBG034, YBG038, YBG130, and YBG469. (B)
Deletion of Set2, Set1, or Dot1 does not prevent
the suppression of the MMS of rad53D by rph1D.
Strains: YBG023, YBG034, YBG607, YBG608, and
YBG609. (C) H3-K36R or H3K9R mutants cannot
prevent the suppression of the MMS of rad53D
by rph1D. Strains: YBG047, YBG610, YBG101,
YBG154, and YBG153. (D) The expression of a
wild-type or demethylase-deﬁcient Rph1 prevents
the suppression by rph1D. Either wild-type or mu-
tated Rph1 versions were integrated in the genome
of a rad53D rph1D strain. Strains: YBG022,
YBG023, YBG034, YBG475, and YBG500.
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to upregulate the levels of several proteins involved in ho-
mologous recombination and increase recombination rates
(Janke et al. 2016), which could explain the suppression
we have seen. Although the exact molecular mechanism by
which MAT heterozygosity confers more resistance to DNA
damage is unknown, some aspects of DNA repair are known
to be under mating-type control; for example, nonhomolo-
gous end joining is repressed and spontaneous recombination
is enhanced in MATa/a cells [reviewed in Haber (2012)].
Our results indicate that the DNA damage sensitivity of
rad53D cells is partially suppressed by loss of the Rpd3L com-
plex (Figure 1 and Figure 2). The loss of Rpd3L does not
lead to hyperresistance to MMS in wild-type cells (Figure
5), indicating that Rpd3L speciﬁcally contributes to MMS
sensitivity primarily in checkpoint-deﬁcient cells. Moreover,
suppression is not prevented by HML deletion, nor is it hap-
loid-speciﬁc (Figure S3), thus ruling out MAT heterozygosity
as an explanation for the suppression. Rpd3L has been shown
to inhibit/delay the activation of. 100 replication origins in
HU in RAD53 cells (Knott et al. 2009). We cannot rule out the
possibility that some deregulation of origin ﬁring in the ab-
sence of Rpd3L may help suppress MMS sensitivity; however,
origin ﬁring is already deregulated in the absence of RAD53,
and this deregulation does not make a major contribution to
MMS survival (Zegerman and Difﬂey 2010). Indeed, deleting
RPD3 results in earlier replication of late origins (Vogelauer
et al. 2002), similar to the effect of deleting RAD53. Rpd3 also
plays an important role in gene regulation (Rundlett et al.
1996). However, new protein synthesis is not required for
viability in HU (Tercero et al. 2003) or in MMS (Figure S4),
arguing that suppression is not due to changes in gene
expression.
The possibility we favor is that hyperacetylated chromatin
somehow directly promotes replication fork stabilization.
Previous data support a positive role for histone acetylation
in fork progression (Choy and Kron 2002;Wurtele et al. 2012;
Kurat et al. 2017), and the S-phase checkpoint has been sug-
gested to facilitate DNA replication fork progression during
replication stress by increasing chromatin accessibility
around replication forks (Rodriguez and Tsukiyama 2013).
Hyperacetylated chromatin might favor replication fork sta-
bilization directly by easing fork progression though a more
open chromatin or indirectly by the recruitment of some es-
sential factor for fork stabilization. Alternatively, more acces-
sible DNA might prevent unscheduled recombination at
stalled forks or enable recombination-dependent fork restart.
Although the consequences of histone acetylation to recom-
binational repair are currently unclear, it is well established
that histone acetylation occurs at double-strand breaks (Bao
2011) and that a complex regulatory network of chromatin
marks is involved in tuning recombination mechanisms
(Clouaire and Legube 2015).
Rad53 might thus inhibit Rpd3L or Rph1, perhaps directly
at stalled forks. We note that Rph1 has been shown to be a
Rad53 target (Kim et al. 2002; Liang et al. 2011) and that its
binding to chromatin has been shown to be inhibited by DNA
damage (Liang et al. 2011), opening up the possibility that
Rph1 is the essential Rad53 target for DNA damage survival.
Among the many putative Rad53 phosphorylation sites in
Rph1, Rph1-S652 has been suggested to be involved in the
dissociation from chromatin upon UV irradiation (Liang et al.
2011). However, we have seen that the rph1-S652A phospho-
defective mutant is not sensitive to MMS (Figure S2B) and
that the phosphomimic rph1-S652D does not cause any sup-
pression of the MMS sensitivity of rad53D (Figure S2B).
Therefore, Rad53 phosphorylation of this site is not sufﬁcient
to explain the role of Rad53 in fork stabilization. We can-
not rule out the possibility that redundant Rad53 phosphor-
ylation sites in Rph1 are involved in this function or that
other Rad53 targets in the Rpd3L complex are involved.
Figure 5 The deletion of NMD factors suppresses the rad53D sensitivity to MMS due to general hyperresistance to DNA damage. (A) Deletions of the
NMD factors Nmd2, Xrn1, or Upf3 suppress the rad53D sensitivity to MMS. Strains: YJT72, YJT75, YBG071, YBG076, and YBG121. (B) nmd2D, but not
rxt2-Q102STOP, is hyperresistant to MMS, CPT, and UV. Strains: YJT72, YJT75, YBG455, YBG071, YBG456, and YBG245. CPT, camptothecin; NMD,
nonsense-mediated mRNA decay; MMS, methyl methanesulfonate; UV, ultraviolet.
510 B. Gómez-González et al.
Addressing this will require a better understanding of Rad53
substrates.
Given the correlation between tumorigenesis and muta-
tions in the S-phase checkpoints (Bartkova et al. 2005;
Gorgoulis et al. 2005), our observation that HDAC depletion
leads to a suppression of lethality of yeast checkpoint mu-
tants is in sharp contrast with the desired toxic effect for
HDAC inhibitors in cancer. A large group of malignancies
is associated with aberrant HDAC expression and activity,
and many HDAC inhibitors have been shown to act synergis-
tically with both chemo- and radiotherapy [reviewed in
Kristensen et al. (2009)]. Paradoxically, and in line with
our observations, HDAC inhibitors have also been shown to
have a radiation-protective effect, as shown for the skin
(Chung et al. 2004). Therefore, the mechanism of fork pro-
tection by histone acetylation both in normal and checkpoint-
defective cells emerges as an interesting mechanism to be
further explored.
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